Your session is about to expire
← Back to Search
ABCp for Lower Back Pain
Phase 2
Recruiting
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 30 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether a new approach to managing low back pain will decrease healthcare resource utilization and improve quality of life.
Who is the study for?
This trial is for family physicians in Alberta treating patients with lower back pain. Physicians must be over 18, speak English, and understand written information to consent. Patients with low back pain due to recent accidents or other clinical trials are excluded.
What is being tested?
The study tests the Alberta Back Carepathway (ABCp) against usual care. ABCp trains physicians in guideline-based interventions for lower back pain at no extra cost, aiming to reduce healthcare resource use and improve quality of life.
What are the potential side effects?
Since this trial involves training in care pathways rather than medication or invasive procedures, traditional side effects are not a concern. However, there may be indirect effects related to changes in patient management.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 30 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 30 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Primary Care visits
Secondary study objectives
GP ordered LBP imaging
GP requested specialist consultations
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ABCpExperimental Treatment1 Intervention
The patient sees MD that follows ABCp, patient then enrolls in ABCp intervention based on MD's categorization of low back pain.
Group II: Usual CareActive Control1 Intervention
The patient receives "usual care" at the clinical site.
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
942 Previous Clinical Trials
434,159 Total Patients Enrolled
Canadian Chiropractic Research FoundationUNKNOWN
1 Previous Clinical Trials
25 Total Patients Enrolled
Bone and Joint Health SCNUNKNOWN
Brandyn Powelske, MScPTStudy DirectorUniversity of Alberta
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- This criterion refers to doctors who are allowed to participate in the study from specific healthcare networks in Edmonton and Calgary.You must be at least 18 years old with no maximum age limit.Your low back pain is from a recent car accident.You have a medical condition that makes it unsafe for you to exercise, like unstable angina or severe aortic stenosis.You have had cancer in the past or are older in age.You have cauda equina syndrome, infection, or a fracture.You are over 70 years old, female, have had a significant injury, or have used corticosteroids for a long time.For the CPC site, participants with a score of 3 or more on the first two questions or on the third and fourth questions of the PHQ4 depression and anxiety screening will not be included.
Research Study Groups:
This trial has the following groups:- Group 1: ABCp
- Group 2: Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.